HomeHealth NewsWho is more likely to lose weight on tirzepatide and why?

Who is more likely to lose weight on tirzepatide and why?

September 14, 2024

- Advertisement -

Scientists have found different weight loss results in people taking tirzepatide. NurPhoto/Getty Images

Tirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity.
A new analysis of the SURMOUNT clinical trials reveals that the medicine, administered as a once-weekly injection, leads to significant weight reduction.
Across all doses and trials, women lost up to 24.6% of their body weight compared to 18.1% in men, indicating a potential…

- Advertisment -